Please use this identifier to cite or link to this item:
|Title:||The Role of Local Therapy for Oligometastatic Prostate Cancer: Should We Expect a Cure?|
|Authors:||Nair, Rajesh;Lamb, Benjamin W;Geurts, Nicolas;Alghazo, Omar;Lam, Wayne;Lawrentschuk, Nathan L;Murphy, Declan G|
|Affiliation:||Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia|
Department of Urology, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China
Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Sir Peter MacCallum Cancer centre, Department of Oncology, University of Melbourne, Melbourne VIC, Australia
|Citation:||The Urologic clinics of North America 2017; 44(4): 623-633|
|Abstract:||The role of local treatment in oligometastatic prostate cancer remains contentious. Treatment of the prostate in metastatic disease may confer benefit, but prospective data are lacking. With improvements in treatments, aggressive strategies directed at metastases have increasingly become of clinical interest. Current evidence suggests good local control can be achieved; however, further data are required to determine overall cancer outcomes. This article evaluates the evidence available and consider whether local treatment of oligometastatic disease is a feasible, safe, and a positive strategy in this disease cohort. Cure should not be expected, although prolonged disease and treatment-free survival may be observed.|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.